NPM1-Positive/FLT3-ITD–Negative Genotype Favorable in AML Patients 55–65 Years Old
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report
J. Clin. Oncol 2015 Feb 23;[EPub Ahead of Print], F Ostronoff, M Othus, M Lazenby, E Estey, FR Appelbaum, A Evans, J Godwin, A Gilkes, KJ Kopecky, A Burnett, AF List, M Fang, VG Oehler, SH Petersdorf, EL Pogosova-Agadjanyan, JP Radich, CL Willman, S Meshinchi, DL StirewaltFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.